B Cell Prolymphocytic Leukemia Treatment, Future Plan, Life Expectancy
My father, Age 63, was diagnosed with "B Cell Prolymphocytic Leukemia" in April 2017 and his treatment started in August 2017, after 3 months of wait and watch.
He has so far received 5 cycles of Rituximab + Bendamustine and is planned to receive 1 more cycle of the same.
Before starting treatment his spleen size had enlarged to18-20 centimeters and white blood cells increased and Haemoglobin, RBCs and Platelets all three decreased.
After 5 cycles spleen size reduced 90% and WBCs decreased and other 3 increased all to about normal ranges.
Is the above said treatment valid in B-PLL and what will be the future plan if the disease relapses and what is life expectancy in this disease.
Regards,
Aftab
Quetta, Pakistan
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards